Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-OPTIMIZE Trial
TCTR20260813003Phase 4Not yet recruiting
- Sponsor
- Bhumibol Adulyadej Hospital Medical Education Department
- Start
- Jun 2026
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of calcium polystyrene sulfonate, sodium zirconium cyclosilicate in hyperkalemia, chronic kidney disease (CKD), sponsored by Bhumibol Adulyadej Hospital Medical Education Department. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
calcium polystyrene sulfonatesodium zirconium cyclosilicate
03
Conditions
hyperkalemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on TCTR20260813003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260813003.